Taysha Gene Therapies, Inc. (TSHA)
5.76
+0.20
(+3.60%)
USD |
NASDAQ |
Dec 11, 16:00
5.76
0.00 (0.00%)
After-Hours: 05:14
Taysha Gene Therapies Market Cap: 1.578B for Dec. 11, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AngioDynamics, Inc. | 553.73M |
| Anavex Life Sciences Corp. | 367.22M |
| Bolt Biotherapeutics, Inc. | 11.23M |
| Neurogene, Inc. | 329.31M |
| Aspire Biopharma Holdings, Inc. | 11.23M |
Market Cap Related Metrics
| PS Ratio | 256.86 |
| PEG Ratio | -0.0171 |
| Price to Book Value | 7.205 |
| Price | 5.76 |
| Earnings Yield | -6.15% |
| PEGY Ratio | -0.0171 |